Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Drug Safety
|
January 1, 1996
Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal
T R Pedersen, J A Tobert
Journal of the American College of Cardiology
|
January 1, 1987
Noninvasive evaluation of the effect of timolol on left ventricular performance after myocardial infarction and the consequence for prognosis
O Brubakk, T R Pedersen, K Overskeid
Current Opinion in Cardiology
|
July 1, 1996
Lipid-lowering therapy for patients with or at risk of coronary artery disease
J Kjekshus, T R Pedersen, J A Tobert
Diabetologia
|
November 7, 1999
The cost-effectiveness of lipid lowering in patients with diabetes: results from the 4S trial
B Jönsson, J R Cook, T R Pedersen
Journal of the American College of Cardiology
|
October 8, 1997
Randomized trial of low molecular weight heparin (dalteparin) in prevention of left ventricular thrombus formation and arterial embolism after acute anterior myocardial infarction: the Fragmin in Acute Myocardial Infarction (FRAMI) Study
F Kontny, J Dale, U Abildgaard, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
June 9, 2009
Effects of a low glycemic load diet versus a low-fat diet in subjects with and without the metabolic syndrome
T O Klemsdal, I Holme, H Nerland, et al.
Physical Review Letters
|
March 5, 2009
Radio pumping of ionospheric plasma with orbital angular momentum
T B Leyser, L Norin, M McCarrick, et al.
Journal of Cardiac Failure
|
April 21, 1998
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
J Kjekshus, T R Pedersen, A G Olsson, et al.
European Heart Journal
|
July 1, 1996
Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S)
B Jönsson, M Johannesson, J Kjekshus, et al.
Diabetes Care
|
April 1, 1997
Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
K Pyŏrälä, T R Pedersen, J Kjekshus, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Drug Safety
|
January 1, 1996
Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal
T R Pedersen, J A Tobert
Journal of the American College of Cardiology
|
January 1, 1987
Noninvasive evaluation of the effect of timolol on left ventricular performance after myocardial infarction and the consequence for prognosis
O Brubakk, T R Pedersen, K Overskeid
Current Opinion in Cardiology
|
July 1, 1996
Lipid-lowering therapy for patients with or at risk of coronary artery disease
J Kjekshus, T R Pedersen, J A Tobert
Diabetologia
|
November 7, 1999
The cost-effectiveness of lipid lowering in patients with diabetes: results from the 4S trial
B Jönsson, J R Cook, T R Pedersen
Journal of the American College of Cardiology
|
October 8, 1997
Randomized trial of low molecular weight heparin (dalteparin) in prevention of left ventricular thrombus formation and arterial embolism after acute anterior myocardial infarction: the Fragmin in Acute Myocardial Infarction (FRAMI) Study
F Kontny, J Dale, U Abildgaard, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
June 9, 2009
Effects of a low glycemic load diet versus a low-fat diet in subjects with and without the metabolic syndrome
T O Klemsdal, I Holme, H Nerland, et al.
Physical Review Letters
|
March 5, 2009
Radio pumping of ionospheric plasma with orbital angular momentum
T B Leyser, L Norin, M McCarrick, et al.
Journal of Cardiac Failure
|
April 21, 1998
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
J Kjekshus, T R Pedersen, A G Olsson, et al.
European Heart Journal
|
July 1, 1996
Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S)
B Jönsson, M Johannesson, J Kjekshus, et al.
Diabetes Care
|
April 1, 1997
Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
K Pyŏrälä, T R Pedersen, J Kjekshus, et al.
Page
of 5